World's Best Scientists 2026 revealed!
Andrew H. Limper

Andrew H. Limper

D-Index & Metrics

Microbiology

D-Index
69
Citations
19805
World Ranking
2019
National Ranking
854

Andrew H. Limper publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Andrew H. Limper sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 316 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Andrew H. Limper D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew H. Limper sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 69 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Andrew H. Limper is a researcher affiliated with the Mayo Clinic in the United States, specializing in the field of Medicine with a focus on Pulmonary and Respiratory Medicine. Their research encompasses several subfields including Epidemiology, Infectious Diseases, Immunology, and Oncology.

The main topics in their work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Pneumocystis jirovecii pneumonia detection and treatment, Pneumonia and Respiratory Infections, Tuberculosis Research and Epidemiology, Antifungal resistance and susceptibility, Medical Imaging and Pathology Studies, and Occupational and environmental lung diseases.

Limper has contributed to numerous publications with notable recent papers such as:

  • Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability (2023, EBioMedicine)
  • Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study (2022, The Lancet Respiratory Medicine)
  • Tissue-resident CD8 + T cells drive age-associated chronic lung sequelae after viral pneumonia (2020, Science Immunology)
  • Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis (2021, Annals of the American Thoracic Society)
  • IPF pathogenesis is dependent upon TGFβ induction of IGF-1 (2020, The FASEB Journal)

The scientist publishes frequently in venues such as bioRxiv (Cold Spring Harbor Laboratory), CHEST Journal, American Journal of Respiratory and Critical Care Medicine, Respiratory Research, and BMC Pulmonary Medicine.

Collaborations are a significant part of Limper's research efforts, with frequent coauthors including Theodore J. Kottom, Eva M. Carmona, Kyle Schaefbauer, Timothy Dempsey, and Lindsey R. Sangaralingham.

Best Publications

  • Medical progress: Pneumocystis pneumonia

    Charles F. Thomas;Andrew H. Limper

  • Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis

    Craig E. Daniels;Mark C. Wilkes;Maryanne Edens;Ted J. Kottom

  • An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

    Andrew H. Limper;Kenneth S. Knox;George A. Sarosi;Neil M. Ampel

  • Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy

    Steven H. Yale;Andrew H. Limper

  • Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS

    Andrew H. Limper;Kenneth P. Offord;Thomas F. Smith;William J. Martin

  • Pulmonary Langerhans'-cell histiocytosis.

    Robert Vassallo;Jay H. Ryu;Thomas V. Colby;Thomas Hartman

  • Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.

    Robert Vassallo;Jay H. Ryu;Darrell R. Schroeder;Paul A. Decker

  • Stretch induces cytokine release by alveolar epithelial cells in vitro.

    Nicholas E. Vlahakis;Mark A. Schroeder;Andrew H. Limper;Rolf D. Hubmayr

  • Fungal infections in HIV/AIDS

    Andrew H Limper;Antoine Adenis;Thuy Le;Thuy Le;Thomas S Harrison

  • Current insights into the biology and pathogenesis of Pneumocystis pneumonia

    Charles F. Thomas;Andrew H. Limper

  • The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung

    Andrew H. Limper;Jacques S. Hoyte;Joseph E. Standing

  • Chemotherapy-induced lung disease

    Andrew H Limper

  • Multiple TLRs Are Expressed in Human Cholangiocytes and Mediate Host Epithelial Defense Responses to Cryptosporidium parvum via Activation of NF-κB

    Xian Ming Chen;Steven P. O'Hara;Jeremy B. Nelson;Patrick L. Splinter

  • Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features.

    Emir Festic;Ognjen Gajic;Andrew H Limper;Timothy R Aksamit

  • Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.

    Deirdre M. O'Riordan;Joseph E. Standing;Kun Young Kwon;Donald Chang

  • Update on the Diagnosis and Treatment of Pneumocystis Pneumonia

    Eva M. Carmona;Andrew H. Limper

  • Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline

    Chadi A Hage;Eva M Carmona;Oleg Epelbaum;Scott E Evans

  • Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses

    Robert Vassallo;Joseph E. Standing;Andrew H. Limper

  • Pneumocystis carinii Cell Wall β-Glucan Induces Release of Macrophage Inflammatory Protein-2 from Alveolar Epithelial Cells via a Lactosylceramide-mediated Mechanism

    Peter Y. Hahn;Scott E. Evans;Theodore J. Kottom;Joseph E. Standing

  • Direct Detection of Legionella Species from Bronchoalveolar Lavage and Open Lung Biopsy Specimens: Comparison of LightCycler PCR, In Situ Hybridization, Direct Fluorescence Antigen Detection, and Culture

    R. T. Hayden;J. R. Uhl;X. Qian;M. K. Hopkins

  • The Overlap Between Respiratory Bronchiolitis and Desquamative Interstitial Pneumonia in Pulmonary Langerhans Cell Histiocytosis: High-Resolution CT, Histologic, and Functional Correlations

    Robert Vassallo;Eric A. Jensen;Thomas V. Colby;Jay H. Ryu

  • Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism.

    O A Hoffman;J E Standing;A H Limper

  • An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP)

    Laurence Huang;Alison Morris;Andrew H. Limper;James M. Beck

Frequent Co-Authors

Edward B. Leof
Edward B. Leof Mayo Clinic
Jay H. Ryu
Jay H. Ryu Mayo Clinic
Ping Yang
Ping Yang Mayo Clinic
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Thomas V. Colby
Thomas V. Colby Mayo Clinic
Frank C. Sciurba
Frank C. Sciurba University of Pittsburgh
Marvin I. Schwarz
Marvin I. Schwarz University of Colorado Denver
Peter B. Bitterman
Peter B. Bitterman University of Minnesota
Hongfang Liu
Hongfang Liu The University of Texas Health Science Center at Houston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse career opportunities. Many aspiring healthcare professionals consider medical degrees online to gain a flexible education that complements their interest in biological sciences.

Public health is another complementary field, with numerous online MPH programs easy to get into available. These programs often appeal to microbiology graduates who want to impact community health through epidemiology or infectious disease control.

Beyond traditional science roles, careers such as child life specialists offer unique paths combining healthcare knowledge with emotional support for young patients. Understanding the child life specialists salary and job outlook can help students decide if this specialty aligns with their goals.

It's also important to consider accessibility in higher education. Various online colleges that accept felons provide opportunities for individuals with past convictions to rebuild careers in science and healthcare fields. This inclusivity highlights the expanding range of options for motivated learners.

Best Scientists Citing Andrew H. Limper

Trending Scientists

Recently Published Articles